Companies / Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
Financials · FY2025
Ownership
165.2M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 8.25% | 13,633,996 |
| 10%+ / strategic | 19.91% | 32,895,674 |
| Institutions | 86.10% | 142,273,309 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all →| Insider | % of shares | Shares |
|---|---|---|
Denner Alexander JDirector | 5.76% | 9,512,490 |
MCCOURT Thomas ACEOChief Executive Officer · Director | 1.15% | 1,898,838 |
Shetzline MichaelSVP, CMO, Head-Res&Drug | 0.40% | 658,037 |
John MinardoChief Legal Officer | 0.30% | 500,498 |
Silver RonaldPrincipal Accounting Officer | 0.25% | 416,570 |
Gaskins Tammi LChief Commercial Officer | 0.21% | 350,350 |
Martini Gregory S.Chief Financial Officer | 0.18% | 297,213 |
Institutional holders 209
View all →| Holder | Value | % of shares |
|---|---|---|
| $74.89M | 10.77% | |
| $54.00M | 9.70% | |
| $53.78M | 9.66% | |
| $53.65M | 9.63% | |
| $38.83M | 6.97% | |
| $37.09M | 5.33% | |
| $28.29M | 4.88% | |
| $26.45M | 4.56% | |
| $20.53M | 3.54% | |
| $16.77M | 3.01% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Denner Alexander J Director | Sell | Class A Common Stock | $20.51M | -6.7M -42.24% | 9,194,435 5.56% of shares | high |
| Feb 24, 2026 | MCCOURT Thomas A CEO | Sell | Class A Common Stock | $378.9K | -104K -6.50% | 1,489,002 0.90% of shares | medium |
| Feb 23, 2026 | MCCOURT Thomas A CEO | Sell | Class A Common Stock | $361.0K | -95K -5.62% | 1,592,528 0.96% of shares | medium |
| Jan 5, 2026 | Silver Ronald Executive | Sell | Class A Common Stock | $162.9K | -35K -11.34% | 276,809 0.17% of shares | medium |
| Feb 24, 2026 | John Minardo Executive | Sell | Class A Common Stock | $69.7K | -19K -4.98% | 363,886 0.22% of shares | low |
| Feb 23, 2026 | John Minardo Executive | Sell | Class A Common Stock | $66.4K | -17K -4.36% | 382,939 0.23% of shares | low |
| Feb 24, 2026 | Shetzline Michael Executive | Sell | Common Stock | $62.3K | +17K +3.37% | 521,425 0.32% of shares | low |
| Feb 23, 2026 | Shetzline Michael Executive | Sell | Class A Common Stock | $59.3K | -16K -2.81% | 538,437 0.33% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| State Street Corporation | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Armistice Capital, LLC | Passive13G/A | — |
| Renaissance Technologies LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| IRWD | — | 46333X108 |